New advances in pancreatic surgery

Current Opinion in Gastroenterology

Volumn 23, Issue 5, 2007, Pages 522-534

  Beger, Hans G ^a   Rau, Bettina M ^b  

^a UNIVERSITY OF ULM   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

Chronic pancreatitis; Cystic neoplasia; Pancreatic cancer; Severe acute pancreatitis

Indexed keywords

EOSIN; HEMATOXYLIN;

ACUTE HEMORRHAGIC PANCREATITIS; ACUTE PANCREATITIS; ADJUVANT CHEMOTHERAPY; ALGORITHM; CANCER CHEMOTHERAPY; CHRONIC PANCREATITIS; CLINICAL DECISION MAKING; DEBRIDEMENT; HUMAN; INFECTION RISK; MORBIDITY; PAIN; PANCREAS RESECTION; PANCREAS SURGERY; PREDICTOR VARIABLE; REVIEW; STENT; SURGICAL DRAINAGE; SYSTEMIC DISEASE; TUMOR CELL;

ACUTE DISEASE; ALGORITHMS; CHEMOTHERAPY, ADJUVANT; HUMANS; PANCREATECTOMY; PANCREATIC CYST; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PANCREATITIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 34548409561     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3282ba56f8     Document Type: Review

References (174)

1. Buter A, Imrie CW, Carter CR, et al. Dynamic nature of early organ dysfunction determines outcome in acute pancreatitis. Br J Surg 2002; 89:298-302.
2. Isenmann R, Rau B, Beger HG. Early severe acute pancreatitis: Characteristics of a new subgroup. Pancreas 2001; 22:274-278.
3. Nagpal K, Minocha VR, Agrawal V, Kapur S. Evaluation of intestinal mucosal permeability function in patients with acute pancreatitis. Am J Surg 2006; 192:24-28.
4. Brown A, Orav J, Banks PA. Hemoconcentration is an early marker for organ failure in necrotizing pancreatitis. Pancreas 2000; 20:367-372.
5. Ryan C, Lewandrowski K, Compton C, et al. Gut macromolecular permeability in pancreatitis correlates with severity of disease in rats. Gastroenterology 1993; 104:890-895.
6. Holland J, Carey M, Hughes N, et al. Intraoperative splanchnic hypoperfusion, increased intestinal permeability, down-regulation of monocyte class II major histocompatibility complex expression, exaggerated acute phase response and sepsis. Am J Surg 2005; 190:393-400.
7. Isenmann R, Rau B, Beger HG. Bacterial infection and extent of necrosis are determinants of organ failure in patients with acute necrotizing pancreatitis. Br J Surg 1999; 86:1020-1024.
8. Garg PK, Madan K, Pande GK, et al. Association of extent and infection of pancreatic necrosis with organ failure and death in acute necrotizing pancreatitis. Clin Gastroenterol Hepatol 2005; 3:159-166.
9. Mayer J, Rau B, Gansauge F, Beger HG. Inflammatory mediators in human acute pancreatitis: clinical and pathophysiological implications. Gut 2000; 47:546-552.
10. Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg 1998; 175:76-83.
11. Brivet FG, Emilie D, Galanaud P. Pro- and anti-inflammatory cytokines during acute pancreatitis: an early and sustained response although unpredictive of death. Parisian Study Group on acute pancreatitis. Crit Care Med 1999; 27:749-755.
12. Powell J, Siriwardena A, Fearon K, Ross J. Endothelial-derived selectins in the development of organ dysfunction in acute pancreatitis. Crit Care Med 2001; 29:567-572.
13. Sakai Y, Masamune A, Satoh A, et al. Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis. Gastroenterology 2003; 124:725-736.
14. Poch B, Gansauge F, Rau B, et al. The role of polymorphonuclear leukocytes and oxygen-derived free radicals in experimental acute pancreatitis: mediators of local destruction and activators of inflammation. FEBS Lett 1999; 461:268-272.
15. Tompkins RG. The role of proinflammatory cytokines in inflammatory and metabolic responses. Ann Surg 1997; 225:243-245.
16. Pezzilli R, Billi P, Miniero R, Barakat B. Serum interleukin 10 in human acute pancreatitis. Dig Dis Sci 1997; 42:1469-1472.
17. Munford RS, Pugin J. Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 2001; 163:316-321.
18. Dugernier T, Laterre PF, Wittebole X, et al. Compartmentalization of the inflammatory response during acute pancreatitis. Am J Resp Crit Care Med 2003; 168:148-157.
19. Guzman E, Rudnicki M. Intricacies of host response in acute pancreatitis. J Am Coll Surg 2006; 202:509-519. This paper presents an overview about dynamics of host responses in severe acute pancreatitis including pro- and anti-inflammatory biologically active compounds and mechanism of decreased immune competence.
20. Ogawa M. Acute pancreatitis and cytokines: second attack by septic complications leads to organ failure. Pancreas 1998; 16:312-315.
21. Johnson CD, Abu-Hilal M. Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis. Gut 2004; 53:1340-1344.
22. Rau BM, Bothe A, Kron M, Beger HG. Role of early multisystem organ failure as major risk factor for pancreatic infections and death in severe acute pancreatitis. Clin Gastroenterol Hepatol 2006; 4:1053-1061. Largest published prospective data analysis objectifying for the first time early multisystems organ failure as outcome determining factor in severe acute pancreatitis.
23. Raraty M, Connor S, Criddle D, et al. Acute pancreatitis and organ failure: pathophysiology, natural history and management strategies. Curr Gastroenterol Rep 2004; 6:99-103.
24. Renner I, Savage W, Pantoja J, Renner VJ. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci 1985; 30:1005-1018.
25. McKay CJ, Evans S, Sinclair M, et al. High early mortality rate from acute pancreatitis in Scotland, 1984 - 1995. Br J Surg 1999; 86:1302-1305.
26. Takeda K, Matsuno S, Sunamura M, Kobari M. Surgical aspects and management of acute necrotizing pancreatitis: recent results of a cooperative national survey in Japan. Pancreas 1998; 16:316-322.
27. LeMee J, Paye F, Sauvanet A, et al. Incidence and reversibility of organ failure in the course of sterile or infected necrotizing pancreatitis. Arch Surg 2001; 136:1386-1390.
28. Rau BM, Bothe A, Beger HG. Surgical treatment of necrotizing pancreatitis by necrosectomy and closed lavage: changing patient characteristics and outcome in a 19 year, single-center series. Surgery 2005; 138:28-39.
29. Rau B, Pralle U, Uhl W, et al. Management of sterile necrosis in instances of severe acute pancreatitis. J Am Coll Surg 1995; 181:279-288.
30. Lillemore K, Yeo CJ. Management of complications of pancreatitis. Curr Probl Surg 1998; 35:3-98.
31. Beger HG, Bittner R, Block S, Büchler M. Bacterial contamination of pancreatic necrosis. Gastroenterology 1986; 49:433.
32. Tao HQ, Zhang JX, Zou SC. Clinical characteristics and management of patients with early acute severe pancreatitis: experience from a medical center in China. World J Gastroenterol 2004; 10:919-921.
33. Halonen KI, Pettila V, Leppaniemi AK, et al. Multiple organ dysfunction associated with severe acute pancreatitis. Crit Care Med 2002; 30:1274-1279.
34. Ruiz-SilvaM, Menchaca-Diaz JL, Siqueira AFRS, et al. Substantial changes in the intestine-derived lymph during bacterial translocation. Transplant Proc 2002; 34:1001-1002.
35. Magnotti L, Upperman J, Yu D, et al. Gut-derived mesenteric lymph but not portal blood increases endothelial cell permeability and promotes lung injury after hemorrhagic shock. Ann Surg 1998; 4:518-527.
36. Mainous M, Ertel W, Chaudry I, Deitch E. The Gut: a cytokine-generating organ in systemic inflammation? Shock 1995; 4:193-199.
37. Juvonen PO, Alhava EM, Takala J. Gut permeability in patients with acute pancreatitis. Scand J Gastroenterol 2000; 12:1314-1318.
38. Wig J, Kochhar R, Ray J, et al. Endotoxemia predicts outcome in acute pancreatitis. Clin Gastroenterol 1998; 26:121-124.
39. Kivilaakso E, Valtonen VV, Malkamäki M, et al. Endotoxaemia and acute pancreatitis: correlation between the severity of the disease and the antienterobacterial common antigen antibody titre. Gut 1984; 25:1065-1070.
40. Bradley EL. A Clinically based classification system for acute pancreatitis. Arch Surg 1993; 128:586-590.
41. Isenmann R, Schwarz M, Rau B, et al. Characteristics of infection with candida species in patients with necrotizing pancreatitis. World J Surg 2002; 26:372-376.
42. Shanmugam N, Isenmann R, Barkin JS, Beger HG. Pancreatic fungal infections. Pancreas 2003; 27:133-138.
43. Gloor B, Müller CA, Worni M, et al. Pancreatic infection in severe pancreatitis: the role of fungus and multiresistant organisms. Arch Surg 2001; 136:592-596.
44. Karimgani J, Porter KA, Levine E, Banks PA. Prognostic factors in sterile pancreatic necrosis. Gastroenterology 1992; 103:1636-1640.
45. Toh SK, Phillips S, Johnson CD. A prospective audit against national standards of the presentation and management of acute pancreatitis in the South of England. Gut 2000; 46:239-243.
46. Porter KA, Banks PA. Obesity as a predictor of severity in acute pancreatitis. Int J Pancreatol 1991; 10:247-252.
47. Rau BM, Schilling MK, Beger HG. Laboratory markers of severe acute pancreatitis. Dig Dis 2004; 22:247-257.
48. Rau BM, Kemppainen EA, Gumbs AA, et al. Early assessment of pancreatic infections and overall prognosis in severe acute pancreatitis by procalcitonin (PCT): a prospective international multicenter study. Ann Surg 2007; 245:745-754.
49. Gross V, Andreesen R, Leser H-G, et al. Interleukin-8 and neutrophil activation in acute pancreatitis. Eur J Clin Invest 1992; 22:200-203.
50. Dellinger EP, Telado J, Soto N. Prophylactic antibiotic treatment in patients with severe acute necrotizing pancreatitis: a double-blind placebo-controlled study. Interscience Conference on Antimicrobial Agents and Chemotherapy 2005; Washington, DC. Ann Surg (in press).
51. Balthazar EJ, Robinson DL, Megibow AJ. Acute pancreatitis: value of CT in establishing prognosis. Radiology 1990; 174:331-336.
52. Moreno R, Vincent JL, Matos R, et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis related Problems of the ESICM. Intensive Care Med 1999; 25:686-696.
53. Wilson C, Heath DI, Imrie CW. Prediction of outcome in acute pancreatitis: a comparative study of APACHE II, clinical assessment and multiple factor scoring systems. Br J Surg 1999; 77:1260-1264.
54. Isenmann R, Runzi M, Kron M, et al. Prophylactic antibiotic treatment in patients with predicted severe acute pancreatitis: A placebo-controlled, double-blind trial. Gastroenterology 2004; 126:997-1004.
55. De Vries A, Besselink M, Buskens E, et al. Randomised controlled trials of antibiotic prophylaxis in severe acute pancreatitis: relationship between methodological quality and outcome. Pancreatology (in press)
56. Mazaki T, Ishii Y, Takayama T. Meta-analysis of prophylactic antibiotic use in acute necrotizing pancreatitis. Br J Surg 2006; 93:674-684.
57. Rünzi M, Niebel W, Goebell H, et al. Severe acute pancreatitis: nonsurgical treatment of infected necrosis. Pancreas 2005; 30:195-199.
58. Ramesh H, Prakash K, Lekha V, et al. Are some cases of infected pancreatic necrosis treatable without intervention? Dig Surg 2003; 20:296-299.
59. Beger HG, Rau B, Isenmann R. Natural history of necrotizing pancreatitis. Pancreatology 2003; 3:93-101.
60. Abou-Assi S, Craig K, O'Keefe SJ. Hypocaloric jejunal feeding is better than total parenteral nutrition in acute pancreatitis: results of a randomized comparative study. Am J Gastroenterol 2002; 97:2255-2262.
61. Olah A, Pardavi G, Belagyi T, et al. Early nasojejunal feeding in acute pancreatitis is associated with a lower complication rate. Nutrition 2002; 18:259-262.
62. McClave SA, Greene LM, Snider HL, et al. Comparison of the safety of early enteral vs parenteral nutrition in mild acute pancreatitis. J Parenter Enter Nutr 1997; 21:14-20.
63. Kalfarentzos F, Kehagias J, Mead N, et al. Enteral nutrition is superior to parenteral nutrition in severe acute pancreatitis: results of a randomized prospective trial. Br J Surg 1997; 84:1665-1669.
64. Gupta R, Patel K, Calder PC, et al. A randomised clinical trial to assess the effect of total enteral and total parenteral nutrition support on metabolic, inflammatory and oxidative markers in patients with predicted severe acute pancreatitis (APACHE II > 6). Pancreatology 2003; 3:406-413.
65. Windsor AC, Kanwar S, Li AG, et al. Compared with parenteral nutrition, enteral feeding attenuates the acute phase response and improves disease severity in acute pancreatitis. Gut 1998; 42:431-435.
66. Büchler MW, Gloor B, Müller CA, et al. Acute necrotizing pancreatitis: treatment strategy according to the status of infection. Ann Surg 2000; 232:619-626.
67. Fernandez-del Castillo C, Rattner DW, Makary MA, et al. Debridement and closed packing for the treatment of necrotizing pancreatitis. Ann Surg 1998; 228:676-684.
68. Sun ZX, Huang HR, Zhou H. Indwelling catheter and conservative measures in the treatment of abdominal compartment syndrome in fulminant acute pancreatitis. World J Gastroenterol 2006; 12:5068-5070.
69. De Waele JJ, Hesse UJ. Life saving abdominal decompression in a patient with severe acute pancreatitis. Acta Chir Belg 2005; 105:96-98.
70. Leppaniemi AK, Hienonen PA, Siren JE, et al. Treatment of abdominal compartment syndrome with subcutaneous anterior abdominal fasciotomy in severe acute pancreatitis. World J Surg 2006; 30:1922-1924.
71. Mier J, Luque-de León E, Castillo A, et al. Early versus late necrosectomy in severe necrotizing pancreatitis. Am J Surg 1997; 173:71-75.
72. Pederzoli P, Bassi C, Vesentini S, et al. Retroperitoneal and peritoneal drainage and lavage in the treatment of severe necrotizing pancreatitis. Surg Gynecol Obstet 1990; 170:197-202.
73. Farkas G, Márton J, Mándi Y, et al. Surgical strategy and management of infected pancreatic necrosis. Br J Surg 1996; 83:930-933.
74. Beger HG, Schlosser W, Friess HM, Büchler MW. Surgical management of necrotizing pancreatitis. Surg Clin North Am 1989; 69:529-549.
75. Mai G, Uhl W, Muller Ch, Büchler MW. The conservative management of severe acute pancreatitis. In: Büchler et al., editors. Acute pancreatitis novel concepts in biology and therapy. Blackwell Science; 1999. pp. 475-485.
76. Hungness ES, Robb BW, Seeskin C, et al. Early debridement for necrotizing pancreatitis: is it worthwhile? J Am Coll Surg 2002; 194:740-744.
77. Farkas G, Márton J, Mándi Y, Leindler L. Surgical management and complex treatment of infected pancreatic necrosis: 18-year experience of a single center. J Gastrointest Surg 2006; 10:278-285.
78. Freeny PC, Hauptmann E, Althaus SJ, et al. Percutaneous CT-guided catheter drainage of infected acute necrotizing pancreatitis: techniques and results. Am J Roentgenol 1998; 170:969-975.
79. Gouzi JL, Bloom E, Julio C, et al. Percutaneous drainage of infected pancreatic necrosis: an alternative to surgery. Chirurg 1999; 124:31-37.
80. Carter CR, McKay CJ, Imrie CW. Percutaneous necrosectomy and sinus tract endoscopy in the management of infected necrosis: an initial experience. Ann Surg 2000; 232:175-180.
81. Horvath KD, Kao LS, Wherry KL, et al. A technique for laparoscopic-assisted percutaneous drainage of infected pancreatic necrosis and pancreatic abscess. Surg Endosc 2001; 15:1221-1225.
82. Castellanos G, Pinero A, Serrano A, et al. Translumbar retroperitoneal endoscopy: an alternative in the follow-up and management of drained infected pancreatic necrosis. Arch Surg 2005; 140:952-955.
83. Connor S, Ghaneh P, Raraty M, et al. Minimally invasive retroperitoneal pancreatic necrosectomy. Dig Surg 2003; 20:270-277.
84. Zhou ZG, Zheng YC, Shu Y, et al. Laparoscopic management of severe acute pancreatitis. Pancreas 2003; 27:46-50.
85. Connor S, Raraty MGT, Howes N, et al. Surgery in the treatment of acute pancreatitis: minimal access pancreatic necrosectomy. Scand J Surg 2005; 94:135-142.
86. Klöppel G, Maillet B. Chronic pancreatitis: evolution of the disease. Hepatogastroenterology 1991; 38:408-412.
87. Schlosser W, Siech M, Görich J, Beger HG. Common bile duct stenosis in complicated chronic pancreatitis. Scand J Gastroenterol 2001; 2:214-219.
88. Büchler MW, Malfertheimer P, Friess H, et al. Chronic pancreatitis with inflammatory mass in the head of the pancreas: a special entity. In: Beger HG, et al., editors. Chronic pancreatitis. Springer 1993. pp. 41-46.
89. Heider TR, Azeem S, Galanko JA, Behrens KE. The natural history of pancreatitis-induced splenic vein thrombosis. Ann Surg 2004; 239:876-880.
90. Beger HG, Schlosser W, Poch B, Gansauge F. Inflammatory mass in the head of pancreas. In: Beger HG, et al., editors. The pancreas. Blackwell Science 1998. pp. 757-760.
91. Schlosser W, Poch B, Beger HG. Duodenum-preserving pancreatic head resection leads to relief of common bile duct stenosis. Am J Surg 2002; 183:37-41.
92. Ebbehoy N, Borly L, Bulow J, et al. Pancreatic tissue fluid pressure in chronic pancreatitits. Relation to pain, morphology, and function. Scand J Gastroenterol 1990; 25:1046-1051.
93. Manes G, Büchler M, Pieramico O, et al. Is increased pancreatic pressure related to pain in chronic pancreatitis? Int J Pancr 1994; 15:113-117.
94. Di Sebastiano P, Mola F, Bockman D, et al. Chronic pancreatitis: the perspective of pain generation by neuroimmune interaction. Gut 2003; 52:907-911.
95. Bockman DE, Büchler MW, Malfertheiner P, Beger HG. Analysis of nerves in chronic pancreatitis. Gastroenterology 1988; 94:1459-1469.
96. Di Sebastiano P, Pink T, Weihe E, et al. Immune cell infiltration and growth-associated protein 43 expression correlate with pain in chronic pancreatitis. Gastroenterology 1997; 112:1648-1655.
97. Di Sebastiano P, Di Mola FF, Di Febbo C, et al. Expression of interleukin 8 (IL-8) and substance P in human chronic pancreatitis. Gut 2000; 47:423-428.
98. Friess H, Zhu ZW, Di Mola FF, et al. Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 1999; 230:615-624.
99. Shrikhande S, Friess H, Mola F, et al. NK-1 receptor gene expression is related to pain in chronic pancreatitis. Pain 2001; 91:209-217.
100. Zhu ZW, Friess H, Wang L, et al. Brain-derived neurotrophic factor (BDNF) is upregulated and associated with pain in chronic pancreatitis. Dig Dis Sci 2001; 46:1633-1639.
101. Beger HG, Schlosser W, Friess HM, Büchler MW. Duodenum-preserving head resection in chronic pancreatitis changes the natural course of the disease. A single-centre experience. Ann Surg 1999; 230:512-523.
102. Dite P, Ruzicka M, Zboril V, Novotny I. A prospective, randomized trial comparing endoscopic and surgical therapy for chronic pancreatitis. Endoscopy 2003; 35:553-558.
103. Cahen D, Gouma D, Yung Nico D, et al. Endoscopic versus surgical drainage of the pancreatic duct in chronic pancreatitis. N Engl J Med 2007; 356:676-684.
104. Beger HG, Büchler MW. Duodenum-preserving resection of the head of the pancreas in chronic pancreatitis with inflammatory mass in the head. World J Surg 1990; 14:83-87.
105. Chaudhary A, Sanjay S, Negi MCh, et al. Complications after Frey's procedure for chronic pancreatitis. Am J Surg 2004; 188:277-281.
106. Schnelldorfer T, Lewin DN, Adams DB. Reoperative surgery for chronic pancreatitis: is it safe? World J Surg 2006; 7:1321-1328.
107. Beger HG, Poch B. Indication for surgical treatment in chronic pancreatitis. In: Beger HG, et al., editors. Diseases of the pancreas. Springer (in press).
108. Eddes EH, Masclee AM, Gooszen HG, et al. Effect of duodenum-preserving resection of the head of the pancreas on endocrine and exocrine pancreatic function in patients with chronic pancreatitis. Am J Surg 1997; 174:387-392.
109. Büchler MW, Friess H, Müller MM, Beger HG. Randomized trial of duodenum-preserving pancreatic head resection versus pylorus-preserving Whipple in chronic pancreatitis. Am J Surg 1995; 169:65-70.
110. Klempa I, Spatny M, Menzel J, et al. Pancreatic function and quality of life after resection of the head of the pancreas in chronic pancreatitis. A prospective, randomized comparative study after duodenum-preserving resection of the head of the pancreas versus Whipple's operation. Chirurg 1995; 66:350-359.
111. Izbicki JR, Bloechle C, Knoefel WT, et al. Duodenum-preserving resection of the head of the pancreas in chonic pancreatitis. A prospective, randomized trial. Ann Surg 1995; 221:350-358.
112. Izbicki JR, Bloechle C, Broering DC, et al. Extended drainage versus resection in surgery for chronic pancreatitis: a prospective randomized trial comparing the longitudinal pancreatico-jejunostomy combinded with local pancreatic head excision with the pylorus-preserving pancreatoduodenectomy. Ann Surg 1998; 228:771-779.
113. Witzigman H, Max D, Uhlmann D, et al. Outcome after duodenum-preserving pancreatic head resection is improved compared with classic Whipple procedure in the treatment of chronic pancreatitis. Surgery 2003; 134:53-62.
114. Izbicki JR, Bloechle CM, Broering DC, et al. Longitudinal v-shaped excision of the ventral pancreas for small duct disease in severe chronic pancreatitis: Prospective evaluation of a new surgical procedure. Ann Surg 1998; 227:213-219.
115. Iacono C, Bortolasi L, Serio G. Indications and technique of central pancreatectomy: early and late results. Langenbecks Arch Surg 2005; 390:266-271.
116. Müller MW, Friess H, Kleeff J, Hinz U, et al. Middle segmental pancreatic resection. Ann Surg 2006; 244:909-918.
117. Longnecker DS, Adler G, Hruban RH, Kloppel G. Intraductal papillary-mucinous neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, editors. World Health Organization classification of tumors. Pathology and genetics of tumors of the digestive system. Lyon: IARC Press; 2000. pp. 237-241.
118. Tanaka M, Chari S, Adsay V, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6:17-32. An international consensus conference presenting a new classification of cystic neoplastic lesions of the pancreas.
119. Sarr MG, Murr M, Smyrk T, et al. Primary cystic neoplasms of the pancreas: neoplastic disorders of emerging importance: current state-of-the-art and unanswered questions. J Gastrointest Surg 2003; 7:417-427.
120. Kimura W. IHPBA in Tokyo 2002: Surgical treatment in IPMT vs MCT: a Japanese experience. J Hepatobiliary Pancreat Surg 2003; 10:156-162.
121. Beger HG, Rau BM, Siech M, et al. Duodenum-preserving pancreatic head resection for cystic neoplastic head lesions. HPB Surg (in press).
122. Schwarz A, Beger HG. Modification of duodenum-preserving pancreatic head resection with segmental resection of the duodenum: experience with four cases (oral presentation). Annual Meeting of the Vereinigung Mittelrheinischer, Chirurgen, Ulm, September 1996.
123. Takada T, Yasuda K, Uchiyama K, Hasegawa H. Duodenum-preserving pancreatoduodenostomy. A new technique for complete excision of the head of the pancreas with preservation of biliary and alimentary integrity. Hep Gastroenterol 1993; 40:356-359.
124. Imaizumi T, Hanyu F, Suzuki M, et al. Clinical experience with duodenum-preserving total resection of the head of the pancreas with pancreaticocholedochoduodenostomy. Hep Bil Pancr Surg 1995; 2:38-44.
125. Nagakawa T, Ohta T, Kayahara M, Ueno K. Total resection of the head of the pancreas preserving the duodenum, bile duct and papilla with end-to-end anstomosis of the pancreatic duct. Am J Surg 1997; 173:210-212.
126. Nakao A. Pancreatic head resection with segmental duodenectomy and preservation of the gastroduodenal artery. Hepatogastroenterology 1998; 45:533-535.
127. Pedrazzoli S, Sperti C, Pasquali C. Pancreatic head resection for non-inflammatory benign lesions of the head of the pancreas. Pancreas 2001; 23:309-315.
128. Isji S, Kawarada Y. Pancreatic head resection with second portion duodenectomy for benign lesions and early stage carcinoma involving the pancreatic head region. Am J Surg 2001; 181:172-176.
129. Ahn YJ, Kim SW, Park YC, et al. Duodenal-preserving resection of the head of the pancreas and pancreatic head resection with second-portion duodenectomy for benign lesions, low-grade malignancies and early carcinoma involving the periampullary region. Arch Surg 2003; 138:162-168.
130. Murakami Y, Uemura K, Yokoyama Y, et al. Pancreatic head resection with segmental duodenectomy for intraductal papillary mucinous tumors of the pancreas. J Gastrointest Surg 2004; 8:713-718.
131. Nakao A, Fernandez-Cruz L. Pancreatic head resection with segmental duodenectomy: safety and long-term results. Ann Surg (in press).
132. Siech M, Thuenmayer SU, Henne-Bruns D, Beger HG. Die Behandlung zystischer Tumoren des Pankreas, radikal oder organsparend? Chirurg 2004; 75:615-621.
133. Efron DT, Lillemoe KD, Cameron JL, Yeo CJ. Central pancreatectomy for benign pancreatic pathology. J Gastrointest Surg 2004; 8:532-538.
134. Christein JD, Kim AW, Golshan MA, et al. Central pancreatectomy for the resection of benign or low malignant potential neoplasms. World J Surg 2003; 27:595-598.
135. Allendorf JD, Schrope BA, Lauerman MH, et al. Postoperative glycemic control after central pancreatectomy for mid-gland lesions. World J Surg 2007; 31:169-170.
136. Hermanek P. Staging of exocrine pancreatic carcinoma. Eur J Surg Oncol 1991; 17:167-172.
137. Takahashi T, Ishikara H, Kato H, et al. Intra-pancreatic, extratumoral perineural invasion. Acta Pathol Jpn 1992; 42:99-103.
138. Ohigashi H, Ishikawa O, Sasaki Y, et al. K-ras point mutation in the nerve plexus around superior mesenteric artery in resectable adenocarcinoma of the pancreatic head. Arch Surg 2000; 135:1450-1455.
139. Kayahara M, Nagakawa T, Konishi I, et al. Clinicopathological study of pancreatic carcinoma with particular reference to the invasion of the extrapancreatic neural plexus. Int J Pancreatol 1991; 10:105-111.
140. Nagakawa T, Kayahara M, Ueno K, et al. A clinicopathologic study on neural invasion in cancer of the pancreatic head. Cancer 1992; 69:930-935.
141. NakaoF A. Harada A, Nonami T, et al. Clinical significance of carcinoma invasion of the extrapancreatic nerve plexus in pancreatic cancer. Pancreas 1996; 12:357-361.
142. Inoue S, Nakao A, Kasai Y, et al. Detection of hepatic micrometastasis in pancreatic adenocarcinoma patients by two-stage polymerase chain reaction/restriction fragment length polymorphism analysis. Jpn J Cancer Res 1995; 86:626-630.
143. Wolfrum F, Vogel I, Fändrich F, Kalthoff H. Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. LAS 2005; 390:430-441.
144. Heeckt P, Safi F, Binder T, et al. Free intraperitoneal tumor cells in pancreatic cancer: significance for clinical course and therapy. Chirurg 1992; 78:2485.
145. Bockman DE, Büchler MW, Beger HG. Interaction of pancreatic ductal carcinoma with nerves leads to nerve damage. Gastroenterology 1994; 107:219-230.
146. Beger HG, Rau B, Gansauge F, et al. Treatment of pancreatic cancer: challenge of the facts. World J Surg 2003; 27:1075-1084.
147. Ando N, Nakao A, Nomoto S, et al. Defection of mutant K-ras in dissected paraaortic lymph nodes of patients with pancreatic adenocarcinoma. Pancreas 1997; 15:374-378.
148. Hosch SB, Knoefel WT, Metz S, et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas 1997; 15:154-159.
149. Tamagawa E, Ueda M, Takahashi S, et al. Pancreatic lymph nodal and plexus micrometastases detected by enriched polymerase chain reaction and nonradioisotopic single-strand conformation polymorphism analysis: a new predictive factor for recurrent pancreatic carcinoma. Clin Cancer Res 1997; 3:2143-2149.
150. Demuere MJ, Doffek KM, Komoiowski RA, et al. Adenocarcinoma of the pancreas. Detection of occult metastases in regional lymph nodes by PCR-based assay. Cancer 1998; 83:1328-1334.
151. Brown HM, Ahrendt SA, Komorowski RA, et al. Immunhistochemistry and molecular detection of nodal micrometastases in pancreatic cancer. J Surg Res 2001; 95:141-146.
152. Niedergethmann M, Rexin M, Hildenbrand R, et al. Prognostic implications of routine, immunohistochemical and molecular staging in resectable pancreatic adenocarcinoma. Am J Surg Pathol 2002; 26:1578-1587.
153. Kanemitsu K, Hiraoka T, Tsuji T, et al. Implication of micrometastases of lymph nodes in patients with extended operation for pancreatic cancer. Pancreas 2003; 26:315-321.
154. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients. Ann Surg 1995; 221:721-731.
155. Millikan KW, Deziel DJ, Silverstein JC, et al. Prognostic factors associated with resectable adenocarcinoma of the head of the pancreas. Am Surg 1999; 65:618-623.
156. Sohn TA, Yeo CJ, Cameron JL, et al. Resected adenocarcinoma of the pancreas: 616 patients: results, outcomes and prognostic indicators. J Gastrointest Surg 2000; 4:567-579.
157. Benassi G, Mastrorilli M, Quarto G, et al. Survival after pancreatico-duodenectomy for ductal adenocarcinoma of the head of the pancreas. Chir Ital 2000; 52:263-270.
158. Neoptolemos JP, Stocken DD, Dunn JA, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg 2001; 234:758-768.
159. Cameron JL, Riall TS, Coleman J, Belcher K. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006; 244:10-15.
160. Yeo CJ, Cameron JL, Maher MM, et al. A prospective randomized trial of pancreaticogastrostomy versus pancreaticojejunostomy after pancreaticoduodenectomy. Ann Surg 1995; 222:580-592.
161. Beger HG, Gansauge F, Schwarz M, Poch B. Pancreatic head resection: the risk for local ans sytemic complications in 1315 patients: a monoinstitutional experience. Am J Surg (in press).
162. Büchler MW, Wagner M, Schied BM, et al. Changes in morbidity after pancreatic resection. Arch Surg 2003; 138:1310-1315.
163. Gordon TA, Burleyson G, Tielsch JM, et al. The effects of regionalization on cost and outcome for one high-risk general surgical procedure. Ann Surg 1995; 221:43-49.
164. Liebermann MD, Killborn H, Lindsey M, et al. Relation of perioperative deaths to hospital volume among patients undergoing pancreatic resection for malignancy. Ann Surg 1995; 222:638-645.
165. Gouma DJ, van Geenen RCI, van Gulik THM. Rates of complications and death after pancreatico-duodenectomy: risk factors and the impact of hospital volume. Ann Surg 2000; 232:786-794.
166. Bramhall SR, Allum WH, Jones AG, et al. Treatments and survival in 13.560 patients with pancreatic cancer and incidence of the disease, in the West Midlands: an epidemiological study. Br J Surg 1995; 82:111-115.
167. Pedrazzoli S, DiCarlo V, Dionigig R, et al. Standard versus extended lymphadenectomy associated with pancreatico-duodenectomy in the surgical treatmen of adenocarcinoma of the head of the pancres: a multicenter, prospective randomized study. Ann Surg 1998; 228:508-517.
168. Yeo CJ, Cameron JL, Lillemoe KD, et al. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity and mortality. Ann Surg 2002; 236:355-366.
169. Nimura Y, Nagino M, Kato H, et al. Regional versus extended lymph node dissection in radical pancreatoduodenectomy for pancreatic cancer: A multicenter, randomized controlled trial. HPB 2004; 6:27.
170. Farnell MB, Pearson RK, et al. A prospective randomized trial comparing standard pancreatoduodenectomy with pancreatoduodenectomy with extended lymphadenectomy in resectable pancreatic head adenocarcinoma. Surgery 2005; 138:618-628.
171. Yeo C, Abrams R, Grochow L, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 1997; 225:621-636.
172. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 2004; 350:1200-1210.
173. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer. JAMA 2007; 297:267-277.
174. Regine WF, Winter KW, Abrams R, et al. RTOG 9704 a phase III study of adjuvant pre and post chemoradiation (CRT) 5-Fu vs. gemcitabine (G) for resected pancreatic adenocarcinoma (oral presentation). J Clin Oncol 2006; 185 (Suppl):4007.